Currently, 99.6% of all Alzheimer drug candidates fail. This is because the organoids available for testing are either animal based, or don’t contain enough complex information. Superior Organoid Technologies has found a way to create human brain-like models that will improve drug testing for brain related diseases.
The challenge was how to promote discovery, innovation, and healing into one unified brand. We were able to take their messaging, and simplify it in a way that will appeal to more than just investors. Through the use of color and copywriting, they are able to articulate their message to create impact.